vMIP-II (1-21)

vMIP-II (1-21), a peptide sourced from viral macrophage inflammatory protein-II (vMIP-II), exhibits exclusive chemokine receptor antagonism by specifically engaging receptors implicated in immunological reactions. Its remarkable anti-inflammatory attributes make vMIP-II (1-21) a compelling candidate for biomedical investigations concerning the modulation of chemokine receptors across diverse pathological conditions, encompassing autoimmune maladies, inflammatory-linked malignancies, and viral afflictions.

Online Inquiry

CAT#GR2184
CAS265650-93-9
M.F/FormulaC108H169N33O27S
M.W/Mr.2425.84
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...

  PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...

 The 70-kDa heat shock protein (HSP70) contains three domains: the ATPase N-domain, which hydrolyses ATP, the sub ...

 Tertiapin-Q (TPN-Q) is a small compact protein that contains twenty-one amino acids, which derived from bee veno ...

 Long-term potentiation (LTP) is a persistent synaptic enhancement which is thought to be a substrate for memory. ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.